Piperidine Market by Industry End-Use Industry (Pharmaceuticals, Agrochemicals, Rubber Industry, and Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026752 | Pages: 100 | Industry: Chemicals and Materials | Date: Oct 2022 | Type: Global

The market crossed the US$ 64.0 billion mark in 2022 and is expected to hit US$ 101.4 billion by 2030, recording a CAGR of 6.0% during the forecast period.

Rising demand for piperidine in the pharmaceutical industry.

Piperidine is a vital compound used in the production of medicinal drugs. They are widely used in anticancer, antimicrobial, anti-inflammatory, analgesic, and antipsychotic drugs. Piperidine and pyridine complexes are 2 of the most common heterocyclic fragments in FDA-approved drugs. Piperidine and its derivatives are ubiquitous building blocks in synthesizing active pharmaceutical ingredients (APIs), intermediates, and fine chemicals. It is a joint organic compound or a representative structure element within many pharmaceutical intermediates. Over the past few years, the incidence of chronic diseases such as coronary artery disease, asthma, chronic obstructive pulmonary disease (COPD), diabetes, hepatitis, arthritis, and cancer has increased significantly in major regions across the globe.

Within the report, the market is segmented into end-use industry and geography. By end-use industry, the market is further segmented into pharmaceuticals, agrochemicals, rubber industries, and others. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

The emergence of piperidine and its derivatives as antiproliferation and antimetastatic drugs.

In the production of drugs, piperidine is a vital compound. It shows various characteristics and is used in different ways as an antipsychotic, anticancer, antimicrobial, and analgesic agent. There are more than one hundred medically accepted chemotherapeutic medications for cancer. However, the toxicological data of most anticancer drugs have restrained their medicinal application as antiproliferative agents. Several piperidine alkaloids isolated from natural herbs exhibited antiproliferation and antimetastatic effects on cancers in vitro and in vivo, such as Piperine, Martine, Evodiamine, Tetrandrine and Berberine. Piperidine derivatives can be utilized as anticancer medications. For instance, the chemotherapy drugs vinblastine and raloxifene employed as antimetastatic and antiproliferation drugs have piperidine structures in their group. Vinblastine is a plant alkaloid which is obtained from Vinca Rosea and is used as an antineoplastic agent. Raloxifene is a second-generation selective estrogen receptor modulator (SERM). It reduces the risk of invasive breast carcinoma in postmenopausal women by acting as an estrogen blocker.

Rising demand in the pharmaceutical med-use industry in the application.

The pharmaceutical sector is the significant industry segment of piperidine. Piperidine is used as an essential component in manufacturing different pharmaceutical products. The characteristics of the nitrogen-bearing heterocyclic ring system present in piperidine, and its derivatives are essentially used in producing different drugs such as antimicrobial, anti-cancer, analgesic, anti-inflammatory, and antipsychotic agents. The market growth is attributed to the growing demand for pharmaceutical drugs for treating chronic diseases and drugs for ageing related.

Recent strategic developments in the piperidine market

The piperidine market has undergone several significant developments, and a few of these have been mentioned below:

  •  In August 2020, Vertellus acquired IM chemicals. IM Chemicals, the intermediates, and the specialities division of ESIM Chemicals. It is a leading provider of speciality chemical products serving the pharmaceutical, coatings, and fuel & lubricant markets. With the addition of chemicals, Vertellus expanded its speciality ingredients portfolio into new markets and bolstered its manufacturing capabilities in Europe.

The piperidine market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. BASF SE, Koei Chemical Co. Ltd., Vertellus, Jubilant Ingrevia Limited, Avantor Inc., and Merck KGaA, are the prominent players operating in the market.

The target audience for the report:

  • Raw material providers
  • Piperidine -related associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities and policymakers
  • Venture capitalists, private equity firms, and start-up companies
  • Piperidine raw material distributors and sales firms
  • Pharmaceuticals industry manufacturers
  • Agrochemicals raw material manufacturers
  • Rubber industry raw material manufacturers
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

  • End-Use Industry:
    • Pharmaceuticals
    • Agrochemicals
    • Rubber Industry
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • BASF SE
    • Koei Chemical Co. Ltd.
    • Vertellus
    • Jubilant Ingrevia Limited
    • Vasudha Pharma

The List of Companies
- BASF SE
- Koei Chemical Co. Ltd.
- Vertellus
- Jubilant Ingrevia Limited
- Vasudha Pharma

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000